Using a standardized protocol, site investigators at 17 sites across 14 U.S. states (
Bronchiolitis
It is often caused by viral infections, such as respiratory syncytial virus (RSV), and can lead to symptoms like coughing, wheezing, and difficulty breathing.
Proper diagnosis and management of Bronchiolitis are crucial for ensuring the best possible outcomes for patients.
This MeSH term provides a concise overview of this important medical condition.
Most cited protocols related to «Bronchiolitis»
We defined an episode of severe pneumonia in hospital setting as any child hospitalized overnight with an admission diagnosis of pneumonia or bronchiolitis. In community-based studies, the presence of lower chest wall indrawing in a child with cough and difficulty breathing with increased respiratory rate for age was used to define a case, using the same cut off values as in the WHO's case definition (4 ,5 ). We recognized that the eligible studies used varying case definitions for the putative risk factors. We therefore grouped the risk factor definitions into categories and analyzed the association between risk factor and outcome for each of these categories (
(i) those that consistently (ie, across all identified studies) demonstrated an association with severe ALRI, with a significant meta-estimate of the odds ratio, would be classified as “definite”;
(ii) those demonstrating an association in the majority (ie, in more than 50%) of studies, with a meta-estimate of the odds ratio that was not significant, would be classified as “likely;” and
(iii) those that were sporadically (ie, occasionally) reported as being associated with severe ALRI in some contexts were classified as “possible.” This classification is consistent with the one originally used by Rudan et al (2 (link)).
We included studies that reported severe pneumonia in children under five years of age (
The included studies used either multivariate or univariate analyses to report the association between the putative risk factors and the outcome, ie severe pneumonia. Since the multivariate design takes into account the interaction with other risk factors and potential confounders, we decided to report the results of the meta-analysis of these data separately. We decided that if there was significant heterogeneity in the data, ie, I2>80%, (corresponding to P < 0.005) (6 (link)), then we would report the meta-estimates from the random effects model (7 (link)). Importantly, we hypothesized that the effects of the risk factors were likely to be different in developing countries and industrialized countries. Because of this, we decided to report the results separately for developing (
The SEEDARE system was approved by the German Federal Commissioner for Data Protection and Freedom of Information, and the ICOSARI system by the RKI and HELIOS Kliniken GmbH data protection authority. As SEEDARE and ICOSARI involved no interventions and the analysis was based on anonymized data only, no ethical clearance was required for them.
We defined a RSV‐ICD‐case based on SEEDARE data as a medical consultation with any of the three RSV‐specific ICD‐10 code diagnoses (J12.1 RSV pneumonia, J20.5 acute bronchitis due to RSV, and J21.0 acute bronchiolitis due to RSV).
We identified the sentinel practices that participated in both SEEDARE and the virological surveillance concurrently by practice‐ID. We matched the medical consultations of SEEDARE with virological samples by practice‐ID, age, gender, consultation date, and sampling date. Only one‐to‐one matches were included for the further data evaluation. We calculated sensitivity of RSV‐specific ICD‐10 code diagnosis as proportion of RSV‐ICD‐cases among confirmed‐RSV‐cases, and specificity as proportion of non‐RSV‐ICD‐cases among non‐confirmed‐RSV‐cases of the identified practices. We calculated sensitivity and specificity of RSV‐specific ICD‐10 code diagnosis among young children, in RSV seasons, and combined with different general ARI ICD‐10 codes J06.‐ acute upper respiratory infections of multiple and unspecified sites (J06, J06.0, J06.8, J06.9), J11.‐ influenza, virus not identified (J11, J11.0, J11.1, J11.8), J12.‐ viral pneumonia, not elsewhere classified (J12, J12.8, J12.9), J18.‐ pneumonia, organism unspecified (J18, J18.0, J18.8, J18.9), J20.‐ acute bronchitis (J20, J20.8, J20.9), J21.‐ acute bronchiolitis (J21, J21.8, J21.9), J22 unspecified ALRI, and B34.9 unspecified viral infection, respectively.
We used Stata (version 15) and
Most recents protocols related to «Bronchiolitis»
Example 14
In contrast to the previous experimental infection using specific pathogen-free Beagles (Crawford et al., 2005), the virus-inoculated mongrel dogs had pneumonia as evidenced by gross and histological analyses of the lungs from days 1 to 6 p.i. In addition to pneumonia, the dogs had rhinitis, tracheitis, bronchitis, and bronchiolitis similar to that described in naturally infected dogs (Crawford et al., 2005). There was epithelial necrosis and erosion of the lining of the airways and bronchial glands with neutrophil and macrophage infiltration of the submucosal tissues (
Therefore, we analyzed data of all children diagnosed with bronchiolitis admitted to our PED between September 2021 and March 2022 (post-COVID period), comparing them to those admitted during the same months in 2020-2021 (COVID period), in 2018-2019 and 2019-2020 (pre-COVID period). In addition, during COVID and post-COVID period nasopharyngeal swabs for the identification of SARS-CoV-2 were obtained from all children admitted in the PED. In some cases, a real-time reverse-transcriptase polymerase chain reaction for the detection of Rhinovirus, RSV, Influenza A and B, Parainfluenza virus, Human metapneumovirus and other Coronaviruses was performed. The study protocol was approved by the Institutional Review Board and Ethics Committee of our institution.
where yw is, for week w, the number of pneumonia and bronchitis hospitalizations.
The baseline level in a given week w was obtained by fitting the model to the observations from 1/07/2012 to 30/06/2018 from which we removed the presence of influenza and bronchiolitis epidemics (Additional file
The number of excess hospitalizations for pneumonia or bronchitis was defined as the sum of the differences between the expected and observed values. This excess was considered attributable to influenza during periods defined as influenza epidemics.
Two model parameters were used: indicators of influenza activity (including influenza-like illness (ILI) incidence data and virological data), and morbidity data for RSV. Weekly ILI incidence data were obtained from the French general practitioner network Sentinelles. Percentages of nasopharyngeal samples testing positive for influenza in France were obtained from the National Reference Center for Influenza. Swabs were performed by practitioners in the Regional Groups for Influenza Surveillance Network (GROG) (until the 2013/2014 influenza season) and by members of the Sentinelles network (from the 2014/2015 influenza season onward). These data were stratified by influenza type and subtype: A(H1N1)pdm09, A(H3N2) and B. For each influenza type and subtype, the product of ILI incidence and the percentage of samples testing positive was used as an indicator of influenza activity. As a proxy for the circulation of RSV, the proportions of consultations for bronchiolitis were obtained from computerized medical records completed during consultations at emergency departments participating in the OSCOUR® network (representing from approximatively 50% of national emergency department activity in 2010-11 to 90% in 2016-17). Model parameters are described in Additional file
The GLM model analysis could only be performed on the five seasons from 2013 to 14 to 2017-18 because of the lack of availability of virological data for influenza before 2013.
The model was adjusted for temporal trend and RSV circulation. We selected lags on influenza activity indicators (lags retained: 0, 1) and the RSV indicator (lags 0, 1), based on the Akaike Information Criterion (AIC). In order to take into account the nonlinear relationship between hospitalizations for pneumonia and bronchitis and covariables, we used b-splines (with three degrees of freedom) on each component [9 (link)]. Population figures were introduced into the model as an offset.
The following regression model was used:
where was the number of pneumonia and bronchitis hospitalizations predicted by the model, was the offset corresponding to the population size, was the time, a function of b-splines with three degrees of freedom, and a function of lag.
The number of pneumonia and bronchitis hospitalizations attributable to influenza was estimated as the difference between the number predicted by the model and the number predicted by the model in the absence of influenza virus circulation. The numbers of weekly pneumonia and bronchitis hospitalizations attributable to influenza estimates were summed to obtain estimates during the five epidemic periods.
We excluded infants hospitalized only for apnoea and with any high-risk conditions for respiratory failure (congenital heart disease, neurologic disorders, and immunodeficiency), those qualified for palivizumab prophylaxis, and those with incomplete clinical data.
Infants were discharged 24 h after they no longer needed respiratory support and they achieved full enteral feeding again, and they no longer needed intravenous infusion.
The primary outcome was the need for respiratory support (either high-flow nasal cannula, nasal continuous positive airway pressure, or mechanical ventilation).
The secondary outcome was the length of hospital stay (days).
Top products related to «Bronchiolitis»
More about "Bronchiolitis"
This ailment is often caused by viral infections, such as respiratory syncytial virus (RSV), and can lead to symptoms like coughing, wheezing, and difficulty breathing.
Proper diagnosis and management of Bronchiolitis are crucial for ensuring the best possible outcomes for patients.
Synonyms for Bronchiolitis include small airway disease, infantile bronchiolitis, and viral bronchiolitis.
Related terms encompass respiratory distress syndrome, asthma, and lower respiratory tract infections.
Abbreviations used in the context of Bronchiolitis include RSV (respiratory syncytial virus) and LRTI (lower respiratory tract infection).
Key subtopics in the study of Bronchiolitis include epidemiology, pathogenesis, clinical presentation, diagnosis (e.g., using SAS 9.4, Stata 15, or the BX41 microscope), treatment (e.g., Penicillin/streptomycin), and prevention (e.g., AIDR 3D, MSwab).
Researchers can leverage innovative tools like PubCompare.ai to optimize their Bronchiolitis studies, locate relevant protocols, and compare findings to enhance reproducibility and accuracy.
Whether you're a clinician, researcher, or healthcare professional, understanding the nuances of Bronchiolitis is essential for providing the best possible care and advancing medical knowledge in this important field.